| Date Filed | Type | Description |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/05/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 08/05/2019 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 08/02/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/01/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 08/01/2019 |
8-K
| Quarterly results |
| 08/01/2019 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Indenture, by and among Select Medical Corporation, the guarantors named therein and U.S. Bank National Association, as trustee",
"Amendment No. 3, to the Credit Agreement, by and among Select Medical Holdings Corporation, Select Medical Corporation, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other lenders and issuing banks party thereto, as amended by Amendment No. 1, and Amendment No. 2",
"Select Medical Corporation Closes Private Placement of $550 Million of 6.250% Senior Notes due 2026" |
|
| 07/31/2019 |
8-K
| Appointed a new director |
| 07/30/2019 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 07/29/2019 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 07/22/2019 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 05/31/2019 |
8-K
| Regulation FD Disclosure |
| 05/02/2019 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/02/2019 |
8-K
| Quarterly results |
| 05/02/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 04/01/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/06/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 02/25/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 02/21/2019 |
8-K
| Quarterly results |
| 02/21/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 01/07/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/04/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/04/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/12/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/04/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/01/2018 |
8-K
| Appointed a new director |
| 11/01/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 11/01/2018 |
8-K
| Quarterly results |
| 10/31/2018 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"Amendment No. 2, to the Credit Agreement, by and among Select Medical Holdings Corporation, Select Medical Corporation, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other lenders and issuing banks party thereto, as amended by Amendment No. 1",
"Amendment No. 4, to the First Lien Credit Agreement, among Concentra Holdings Inc., MJ Acquisition Corporation, Concentra Inc., the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative and Collateral Agent, as amended by Amendment No. 1, Amendment No. 2, and Amendment No. 3" |
|
| 10/11/2018 |
8-K
| Quarterly results |
| 08/03/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/02/2018 |
8-K
| Quarterly results |
| 08/02/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 05/08/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
|